398 related articles for article (PubMed ID: 1331019)
1. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Neu HC; Chin NX; Gu JW
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
[TBL] [Abstract][Full Text] [Related]
3. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
Maskell JP; Sefton AM; Williams JD
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
[TBL] [Abstract][Full Text] [Related]
5. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
6. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.
Fernandes PB; Baker WR; Freiberg LA; Hardy DJ; McDonald EJ
Antimicrob Agents Chemother; 1989 Jan; 33(1):78-81. PubMed ID: 2523688
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of RU-66647, a new ketolide.
Jones RN; Biedenbach DJ
Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
[TBL] [Abstract][Full Text] [Related]
8. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 1999 Nov; 43(11):2801-5. PubMed ID: 10543769
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 2000 Sep; 44(9):2525-9. PubMed ID: 10952607
[TBL] [Abstract][Full Text] [Related]
10. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of dirithromycin in comparison with other new and established macrolides.
Bauernfeind A
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():39-49. PubMed ID: 8478311
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
Rolston KV; Ho DH; LeBlanc B; Bodey GP
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):30-3. PubMed ID: 2137413
[TBL] [Abstract][Full Text] [Related]
13. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.
Fass RJ
Antimicrob Agents Chemother; 1993 Oct; 37(10):2080-6. PubMed ID: 8257127
[TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
Eliopoulos GM; Reiszner E; Ferraro MJ; Moellering RC
J Antimicrob Chemother; 1987 Nov; 20(5):671-5. PubMed ID: 2962974
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
Brumfitt W; Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
[TBL] [Abstract][Full Text] [Related]
16. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of anaerobic bacteria from the human oral cavity.
Baker PJ; Evans RT; Slots J; Genco RJ
J Dent Res; 1985 Oct; 64(10):1233-44. PubMed ID: 3861655
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens.
Merriam CV; Citron DM; Tyrrell KL; Warren YA; Goldstein EJ
Int J Antimicrob Agents; 2006 Sep; 28(3):244-8. PubMed ID: 16875802
[TBL] [Abstract][Full Text] [Related]
20. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
